Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents - Test2 - elhamkhani - TriplyDB

Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents

Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents

http://www.wikidata.org/entity/Q27487357

about

Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever Structure and functionality in flavivirus NS-proteins: perspectives for drug design T-705 (favipiravir) inhibition of arenavirus replication in cell culture Neurological approaches for investigating West Nile virus disease and its treatment in rodents Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106 Effect of T-705 treatment on western equine encephalitis in a mouse model Progress on the development of therapeutics against West Nile virus Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever Structure and function of the Zika virus full-length NS5 protein ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION.Antiviral strategies for pandemic and seasonal influenza Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus T-705 (favipiravir) activity against lethal H5N1 influenza A viruses Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.Favipiravir (T-705), a novel viral RNA polymerase inhibitor.Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak Maporal virus as a surrogate for pathogenic New World hantaviruses and its inhibition by favipiravir.Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic Implications Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters.Ebola Virus Infection: Overview and Update on Prevention and Treatment.Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome.Highlights in antiviral drug research: antivirals at the horizon.Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.Development of experimental and early investigational drugs for the treatment of Ebola virus infections.Extinction of West Nile virus by Favipiravir through lethal mutagenesis.Clinical Evaluation of Ebola Virus Disease Therapeutics.Treatment with a Nucleoside Polymerase Inhibitor Reduces Shedding of Murine Norovirus in Stool to Undetectable Levels without Emergence of Drug-Resistant Variants.Viruses in Rodent Colonies: Lessons Learned from Murine Noroviruses.Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases.Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase.Zika virus (ZIKV) Replication is Substantially Inhibited by Novel Favipiravir and Interferon-alpha Combination Regimens.Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.West Nile virus

P2860

Q21092271-5663BC91-B1D3-45DE-B8EF-6EB27C2F2A9F Q23011530-232BCC28-31D9-4811-B430-0C99F2077532 Q24633241-C1C9C82E-1E4E-4B0E-B37F-33C3FF15DC3A Q27009096-C318D5F3-62C4-47FD-94B8-560005038E67 Q27487527-B1F071BC-048D-4B9B-82A0-E42F9D629F1F Q27488864-06FDA199-66ED-4125-B9B2-C7FFCECFFB55 Q27489893-948D7A44-394F-454F-9F1A-BB47A761019B Q27490937-EFD3D918-AFB7-4743-9853-B01C8F7D1129 Q28474006-F09E98E6-E07D-4F78-987B-DE38A6E52362 Q28477434-A82D1754-3971-482E-B44A-75746204815A Q29365369-0B819B1E-E105-4418-8D12-0657F082C1FF Q30404586-2CCE39CE-D4F5-4B4D-860A-790C7EFC8E2A Q30408116-FAB4226C-0910-4138-BF71-C2B4083A9DE5 Q33433096-F53D390F-3C55-488F-932A-23EAB69D82FC Q33639979-AE1B6F45-CF8D-4E8E-B85B-975CEE9D16AB Q34274569-057CFC6F-E414-4392-81A2-EFB7C9B5E4E6 Q34374652-344EED8A-8A6B-4D27-B13E-62B9A3A41601 Q34432483-864042C2-8D8D-4887-818E-380DF4EF3847 Q35598919-5680DFD3-6F82-41CD-B4BD-335DFC6AF72F Q35624775-4CA1659E-7223-4E23-98A2-CFA83A91D3DE Q35784542-78D42090-D7BF-43F7-A469-12FF7A477179 Q36166222-31651119-A008-4C4D-A44A-367743500534 Q36202563-93D2CF3D-9F27-4D3D-97A0-635D1325BF78 Q36363253-613C90BF-F48C-4EE7-9C15-C31C157CD7CC Q36705853-7347455C-717C-4EC4-91DA-9312B7B5C168 Q37120083-D454C3F1-5E76-478D-AEFC-0440443B48C0 Q37263923-3A9A050D-1E87-4151-8728-4CC0E753D1E5 Q38007145-B0CA288E-F099-4ACF-8E94-43DCC4E427F7 Q38158967-47E1A138-B88F-425F-85D1-0BC288DD22D7 Q38524949-9BFD49B0-F224-4F4C-9A4E-0CEE8816D4F9 Q38605122-68D030CB-9BD5-4AD7-8E49-5E91FDE211F6 Q38617605-428263DE-035E-47EF-98FA-B627055A17F6 Q38741925-C2E87FAE-D4EE-4078-B654-778CC316F8B7 Q38766728-0349ADAD-1DE4-4352-A63D-AD4766D83D10 Q38833628-F6E0B8F7-5A26-4CEF-AF4E-9026D763DB66 Q40044875-04A61731-EB71-412F-BEE3-1DF06D812498 Q42110040-1C584EEE-36AE-4A93-88D0-9147327148C0 Q43046770-C12A9BA6-AE63-48D1-9B1A-F4E3C4B0B3F3 Q54256710-BD9CEF65-6AA9-4C0A-A3C0-19EE5816822C Q56932479-CCC2CB08-1DF8-497C-93E0-60542E9B2213

P2860

Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents

http://www.wikidata.org/entity/Q27487357

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Efficacy of orally administere ...... ile virus infection in rodents

@ast

Efficacy of orally administere ...... ile virus infection in rodents

@en

Efficacy of orally administere ...... ile virus infection in rodents

@nl

type

label

Efficacy of orally administere ...... ile virus infection in rodents

@ast

Efficacy of orally administere ...... ile virus infection in rodents

@en

Efficacy of orally administere ...... ile virus infection in rodents

@nl

prefLabel

Efficacy of orally administere ...... ile virus infection in rodents

@ast

Efficacy of orally administere ...... ile virus infection in rodents

@en

Efficacy of orally administere ...... ile virus infection in rodents

@nl

P1433

Q27487357-D60E4DF4-4565-407E-A111-E23BBB7CD973

P1476

Q27487357-CAA7EF12-501E-4B45-9D9A-DE375454E0DF

P2093

Q27487357-03C0E256-95D7-4942-BF81-61BA384E8BD3

Q27487357-2B7D987F-9C6E-481F-9114-9D092B6D4F62

Q27487357-2DA5E240-5A4B-498B-8083-5587A426AE29

Q27487357-F9F0CE99-023A-4BDC-9C1A-7BC8B354D18D

P2860

Q27487357-36A54352-EEEA-4640-936A-22566E008808

Q27487357-3926A49D-853D-45A9-9F87-54960118B05C

Q27487357-4C31D6BA-B59B-4B02-A60C-C6A9E838B399

Q27487357-6B236AC5-79FF-4EEF-A1C7-41E15A89E6A1

Q27487357-9A2EFFB2-70F8-4C55-B22E-5F5E32611C82

Q27487357-BB0CAB85-59D1-43A4-8F4E-EE43C2E365A0

Q27487357-C0CA6862-A876-4306-9C01-E3529BC09C81

Q27487357-DBD259AB-7C19-4FA2-B002-D663504E23EA

Q27487357-F72FE05D-5CDD-4426-9B85-60A89C053552

P304

Q27487357-6CED1469-A412-435E-9948-CCDF49A5486B

P31

Q27487357-AC624610-AF15-4B67-B2B4-00FA9CE49BA7

P3181

Q27487357-C2DDC699-10B2-4BB0-B7F6-3C73A62E83E5

P356

Q27487357-4B0F0C8C-D35F-4477-8C38-92588B1B2A57

P433

Q27487357-FA96B877-D6C2-4B1C-A93B-BA0FD7239E31

P478

Q27487357-D3226C92-F7FA-4CC7-81AD-ED4C3024A4F2

P50

Q27487357-018939B3-BA48-4CB4-975D-44E27F652429

Q27487357-6B2617D4-C3D0-4F29-8E10-6128DC217F44

Q27487357-F7D9C254-18C2-46AB-8388-B50B6A5C0D94

P577

Q27487357-D4713246-EB00-4668-802C-2426E45EA7B1

P5875

Q27487357-F5FB3234-3247-4E0E-BDDE-11E10B998894

P698

Q27487357-191BC9CC-51FD-4BD7-B7DC-38004BE94EB5

P921

Q27487357-276A9BFC-38CB-4C48-8B88-DC86A082D3ED

Q27487357-C0B93ACC-86FE-465A-AE07-516989B73D3B

P932

Q27487357-D0447593-952D-41C4-93D5-3A851FF09167

P3181

P356

J.ANTIVIRAL.2008.07.009

P1433

Antiviral Research

P1476

Efficacy of orally administere ...... ile virus infection in rodents

@en

P2093

Andrew J Christensen

http://www.w3.org/2001/XMLSchema#string

Brandon S Taro

http://www.w3.org/2001/XMLSchema#string

Hong Wang

http://www.w3.org/2001/XMLSchema#string

Yousuke Furuta

http://www.w3.org/2001/XMLSchema#string

P2860

Defining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster Model

In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections

Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.

Identification of active antiviral compounds against a New York isolate of West Nile virus.

In vitro and in vivo activities of anti-influenza virus compound T-705.

Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.

Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.

Mechanism of action of T-705 against influenza virus.

In vitro and in vivo activities of T-705 and oseltamivir against influenza virus.

P304

377-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2939336

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.ANTIVIRAL.2008.07.009

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Venkatraman Siddharthan

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23228481

http://www.w3.org/2001/XMLSchema#string

P698

18762216

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

P932

2587511

http://www.w3.org/2001/XMLSchema#string